Molecular biological advances have changed our world for the good, and I am the first to jump up and applaud them. But it is equally important that we don’t let the volume of that applause drown out the voices that offer alternative solutions.
The U.S. Supreme
Court has been considering exhaustion of intellectual property rights this term, and in one case decided and one pending, these considerations could impact
the availability of meaningful patent protection for drugs, vaccines and other biological products
Core Informatics and OpenEye Scientific Software announce partnership and their integration of OpenEye
cheminformatics software into Core Informatics’ web-based Laboratory Information Management System and Electronic Lab Notebook
In researching our cover story on the sequestration -- or, put in very stark, black-and-white terms, $85 billion in across-the-board cuts to
federal government spending -- and how it is expected to affect biomedical research in every state, I was treated to a slew of colorful comparisons by
researchers, trade groups and government leaders, as they grapple to explain the hit they will take when the NIH is forced to cut its budget by 5.1 percent,
or $1.6 billion, this fiscal year.